Send by PR Newswire (press release)

Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese (Body Mass Index, or BMI, [...]

Send by Tampabay.com

The study, as well as another lorcaserin trial involving 4000 people, was completed. The data showed people on the drug for a year lost an average of 5.8 [...]

Send by The Money Times

A decision on lorcaserin especially could be delayed since the FDA advisory panel met just last month. What's the chance of lorcaerin and Qnexa gaining FDA [...]

Send by FierceBiotech

The FDA has issued a Complete Response Letter to Arena Pharmaceuticals rejecting an immediate approval for the weight drug lorcaserin and pointing the [...]

Send by MedPage Today

In a complete response letter to Arena, the FDA said "the weight loss efficacy of lorcaserin in overweight and obese individuals without type 2 diabetes is [...]

Send by Medical News Today

Citing cancer risks as one of its reasons, lorcaserin, an experimental drug for obesity treatment and maintenance of weight loss, was turned down by the [...]

Send by TheStreet.com

And "rats," as in regulators want to see a lot more data with regard to high doses of lorcaserin possibly causing breast cancer and brain tumors in the [...]

17 Sep 2010 Yesterday, the FDA advisory committee voted 9 to 5 against approval of Arena Pharmaceuticals' (ARNA) Lorcaserin. I listened to the day long [...]

16 Sep 2010 Lorcaserin, Arena's most advanced drug candidate, is the second diet drug to stumble in a race among three small companies to launch the [...]

16 Jul 2010 Lorcaserin works on the serotonin receptor, a hormone that controls appetite. Although the weight loss was not extreme, lorcaserin does not [...]

It was a bit of a rollercoaster day for Arena, since shares soared earlier today because of new lorcaserin data published in the New England Journal of [...]

8 Jul 2010 The long Fourth of July holiday weekend made for a short week of life sciences news in San Diego. Even if I made short work of this week's [...]

6 Aug 2010 Here are some highlights I took from that article on why I think Lorcaserin will be a major blockbuster and has the potential for being one [...]

15 Jul 2010 Experimental Drug Helped People Lose 5 Percent of Body Weight and Keep it Off with Minimal Side Effects Read more by Neil Katz on CBS News' [...]

14 Jul 2010 Arena Pharmaceuticals Inc.'s experimental weight-loss drug, which would become the company's first marketed product if approved, [...]

Send by Andy Dufrane

Shares of Arena Pharmaceuticals Inc. tumbled in premarket trading Friday, a day after a Food and Drug Administration panel rejected its weight loss pill lorcaserin. An FDA panel of experts voted 9-5 against the drug on Thursday, [...]

Send by Jeniffer Winget

The panel strategically analyzed the drug study data and they discovered that lorcaserin that did not outweigh the benefits, including cancer, tumors, and depression. The drug was proven to do more harm than to help people lose weight. [...]

The US Food and Drug Administration's Endocrinologic and Metabolic Drugs Advisory Committee yesterday voted nine to five against approval of Arena Pharmaceutical (Nasdaq: ARNA) and Japanese drugmaker Eisai's (TYO: 4523) obesity drug [...]

Send by Robert Langreth

If it were the 1990s, lorcaserin might already be on the market. But the FDA has become significantly more conservative about mass market drugs in the wake of drug safety scandals like Redux (from Wyeth/Pfizer for obesity) and Vioxx [...]

Japan Lawmakers Seek Diet Resolution on Claim to Disputed Isles A group of ruling-party and opposition Japanese lawmakers plans to submit a Diet resolution re-asserting the country’s claim over uninhabited islands at the center of a dispute with China that has soured relations. Read more on Bloomber [...]

Arena Pharmaceuticals, Inc. Lorcaserin hydrochloride (APD356) 13 August 2010. Page 2 of Neoplasms in Female Rats and Lorcaserin Exposure Margins Above Human [...]

The U.S. Food and Drug Administration declined to approve Arena Pharmaceuticals Inc.'s obesity drug lorcaserin, raising questions about the drug's effectiveness and seeking more information about its cancer risk. The San Diego company, [...]

Diet pill lorcaserin shot down by the FDA Health Jackal Lorcaserin rejection is the latest in a chain of bad news for diet drugs in United States. Arena is in a three-way race with Orexigen Therapeutics Inc. and … [...]

Canadian Press, The ”Canadian Press DataFile Delayed ” Arena Pharmaceuticals Inc. on Saturday said the Food and Drug Administration has rejected the company’s application for lorcaserin, one of three drugs seeking to become the first new FDA -approved prescription weight loss drug in more than a dec [...]

(AP) - Arena Pharmaceuticals Inc. on Saturday said the Food and Drug Administration rejected the company's application for lorcaserin, one of three drugs seeking to become the [...]